McClish A .1966 .Diazepam as an intravenous induction agent for general anaesthesia. Can Anaesth Soc J, 13(6) : 562-75.
. .. , : .
Dalen JE,Evans GL,Banas JS,Brooks HL,Paraskos JA,Dexter L .1969 .The hemodynamic and respiratory effects of diazepam (Valium). Anesthesiology, 30(3) : 00000542-63.
Rubin A,Allen GD,Everett GB .1978 .Induction of general anesthesia with diazepam or thiopental: a comparison of the cardiorespiratory effects. Anesth Prog, 25(2) : 39-44.
AD Fraser .1998 .Use and abuse of the benzodiazepines. Ther Drug Monit, 20(5) : 00007691-9.
Yasumori T,Nagata K,Yang SK,Chen LS,Murayama N,Yamazoe Y .1993 .Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in Ndemethylation in the substrate concentration-dependent manner. Pharmacogenetics, 3(6) : 00008571-301.
Tutton R. .2012 .Personalizing medicine: futures present and past. Soc Sci Med, 07(10) : 1721-8.
.2005 .Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy. Philos Trans R Soc Lond B Biol Sci, 360(1460) : 1563-70.
.2010 .. , 16(2) : 204-19.
.2004 .. , 31(3) : 144-8.
Miller SA,Dykes DD,Polesky HF DD .1988 .A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res, 16(3) : 1215.
Aynacioglu AS,Brockmöller J,Bauer S,Sachse C,Güzelbey P,Ongen Z .1999 .Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin. Br J Clin Pharmacol, 00012(3) : 2125-15.
Sviri S,Shpizen S,Leitersdorf E,Levy M,Caraco Y .1999 .Phenotypicgenotypic analysis of CYP2C19 in the Jewish Israeli population. Clin Pharmacol Ther, 9236(99) : 70106-2.
Karczewski KJ .2013 .Progress in genomics according to bingo: 2013 edition. Genome Biol, 14(12) : 143.
Adam J.,Pharmacogenomics Personalized,Medicine Personalized .2008 .. Nature Edu, 1 : 194.
Lemmens HJ,Stanski DR .2012 .Individualized dosing with anesthetic agents. Clin Pharmacol Ther, 92(4) : 417-9.
Galley HF,Mahdy A,Lowes DA .2005 .Pharmacogenetics and anesthesiologists. DOI: 10.2217/14622416.6.8.849, 6(8) : 849-56.
Hinz B,Cheremina O,Brune K. .2008 .Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J, 22(2) : 8506com-90.
Kalsi SS,Wood DM,Waring WS,Dargan PI .2011 .Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose?. Open Access Emerg Med, 3 : 69-76.
Qin XP,Xie HG,Wang W,He N,Huang SL,Xu ZH .1999 .Effect of the gene dosage of CgammaP2C19 on diazepam metabolism in Chinese subjects. Clin Pharmacol Ther, 9236(99) : 90075-9.
Yoshimoto K,Echizen H,Chiba K,Tani M,Ishizaki T .1995 .Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2. Br J Clin Pharmacol, 39(4) : 2125-31.
Sanz EJ,Villén T,Alm C,Bertilsson L C .1989 .S-mephenytoin hydroxylation phenotypes in a Swedish population determined after coadministration with debrisoquin. Clin Pharmacol Ther, 45(5) : 495-9.
Andersson T,Miners JO,Veronese ME,Birkett DJ .1994 .Diazepam metabolism by human liver microsomes is mediated by both Smephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol, 38(2) : 2125-7.
Jung F,Richardson TH,Raucy JL,Johnson EF .1997 .Diazepam metabolism by cDNA-expressed human 2C P450s: identification of P4502C18 and P4502C19 as low K(M) diazepam Ndemethylases. Drug Metab Dispos, 25(2) : 133-9.
Bertilsson L,Henthorn TK,Sanz E,Tybring G,Säwe J,Villén T. .1989 .Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clin Pharmacol Ther, 45(4) : 348-55.
Ghoneim MM,Korttila K,Chiang CK,Jacobs L,Schoenwald RD,Mewaldt SP,Kayaba KO .1981 .Diazepam effects and kinetics in Caucasians and Orientals. Clin Pharmacol Ther, 29(6) : 749-56.